Description
Substance Use Disorders (SUDs) are highly prevalent in the United States and contribute to significant disease burden. However, effective screening and treatment for these conditions remains challenging to implement, despite significant upward trends in associated morbidity and mortality. Between June 2020 and June 2021, the number of drug overdose deaths in the United States increased by nearly 19%; however, recent estimates from the California Healthcare Foundation are that only 10% of those who meet criteria for a substance use disorder receive any type of treatment. Despite increasing prevalence and barriers to care, substance use disorders can be effectively prevented, treated, and managed if evidence-based practices are implemented in an equitable fashion. Integrating substance use disorder treatment into primary care has been shown to reduce acute healthcare utilization for patients with SUD, including emergency room visits and length of hospital stays. Our session will focus on an initiative at UC Davis Health to integrate substance use screening and treatment into primary care settings, with a particular aim to serve medically underserved communities. This project is funded by the California Healthcare Foundation and the Center for Care Innovation and is led by a multidisciplinary team at UC Davis Health. We will begin by reviewing recent national, state and UC Davis Health-level data related to substance use disorders, screening, and treatment, and examine the barriers, including stigma, that contribute to challenges in care. In small groups, we will ask participants to discuss barriers they have experienced when screening for and treating substance use disorders, which will be followed by a debrief with the larger group. Next, we will describe the equity-based, phased approach that UC Davis Health is integrating into substance use screening and treatment within primary care. The initial phase includes integrated treatment using a stepped care model at primary care sites that have a higher population of medically underserved persons. This approach is unique in that it aims to meet patient needs by bringing treatment directly to them within the primary care setting, rather than referring to an outside specialty clinic. Presenters will share workflows and clinic operations, including the addition of an SUD Licensed Clinical Social Worker (LCSW) embedded in primary care. We will also discuss quality metrics and how we are linking these services to existing primary care mental health integration efforts. To conclude the session, we will describe plans for later phases of the project to use data-driven tools to examine the presence of disparities in our substance use disorder populations by race, ethnicity, age, language, sexual orientation, and gender—and to further explore the intersectionality of these demographics. From there, we will share our intent to build equity-tailored workflows to address disparities in our populations.
Format
Recorded webinar.
This content was recorded during the APA 2023 Annual Meeting.
Learning Objectives
- Assess the increase in prevalence of substance use disorders in the United States and the extent to which the Covid-19 pandemic has exacerbated this issue.
- Implement screening and integrate treatment and navigation resources for substance use disorders into primary care for people who are medically underserved.
- Develop data-driven tools to examine the presence of disparities in substance use disorder populations by race, ethnicity, age, language, sexual orientation, and gender.
- Design culturally tailored substance use interventions for disparity populations.
Target Audience
Residents/Fellows, Psychiatrists, Psychologists
Estimate Time to Complete
Estimated Duration: 1.25 hours
Program Start Date: May 1, 2025
Program End Date: May 1, 2028
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The APA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Instructors
- Lorin Scher, MD
- Alvaro Gonzalez, MA, AMFT
- Jeremy DeMartini, MD
- Annabelle Ostrander, MHA
Planners
- Vishal Madaan, MD, Chief of Education and Deputy Medical Director at the American Psychiatric Association.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance